In their subsequent study, the authors showed that coregulation of alternative splicing by hnRNPM and ESRP1 is widespread and primarily antagonistic in breast cancer cells, although a subset of events is regulated concordantly (Harvey et al., 2018). The gene discussed is ESRP1; the disease is breast cancer.